Sign in
4

Changes in Ownership

IOVANCE BIOTHERAPEUTICS, INC. Filed Acc 0001104659-26-106750

Chief Operating Officer gave up 3,976 shares (to pay taxes)

  • Chief Operating Officer acquired 7,813 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

BILINSKY IGOR · Chief Operating Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2026-09-08 Exercise or conversion : show line 1 in the form +7,813 146,050 D
2026-09-08 Shares withheld for taxes : show line 2 in the form −3,976 $8.70 $34,591 142,074 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-09-08 Exercise or conversion : show line 3 in the form Restricted Stock Units −7,813 46,878 D
Loading xslF345X06/tm2625111-2_4seq1.xml…